StockWatch
·
Q2 FY-2027 RESULTS · STYRENIX

Styrenix consolidated PAT sinks 48% YoY, 83% QoQ as Thailand unit swings to ₹30 Cr loss

PAT -48.2% YoY · revenue +24.4% · margins compressing

Q2 FY27 resultsSTYRENIXStyrenix Performance Materials Ltd28 Oct 2026 · 3 min read
Revenue

₹993.51 Cr

+24.4% YoY

PAT (consolidated)

₹23.17 Cr

-48.2% YoY

Net margin

2.32%

-3.3pp YoY

EPS

₹13.18

Styrenix Performance Materials' consolidated PAT fell 48.2% YoY to ₹23.17 Cr (from ₹44.72 Cr in Q2 FY26) and 83.2% QoQ (from ₹138.30 Cr in Q1 FY27), even as consolidated revenue rose 24.4% YoY to ₹993.51 Cr, though it slipped 1.7% QoQ from ₹1,010.86 Cr. Consolidated EPS fell to ₹13.18 from ₹78.64 in Q1 FY27 and ₹25.43 a year ago. On a standalone (India) basis the picture is materially different: PAT was nearly flat YoY at ₹51.20 Cr (vs ₹50.78 Cr), a greater than 3% divergence from the consolidated YoY move that readers should note — the consolidated miss is driven almost entirely by the Thailand step-down subsidiary swinging to a ₹(29.62) Cr net loss on ₹226.15 Cr of revenue this quarter, reviewed by other auditors per the limited review report; the UAE subsidiary (FZE) is dormant and immaterial.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹993.51 Cr-1.7%+24.4%
Expenses₹921.7 Cr+11.6%+23.7%
PAT₹23.17 Cr-83.2%-48.2%
Net margin2.32%-11.3pp-3.3pp
EPS₹13.18-83.2%-48.2%

Margins compressed sharply at the group level: NPM fell to 2.32% from 13.64% in Q1 FY27 and 5.58% a year ago, while OPM (EBITDA excluding other income, over revenue) fell to 7.23% from 21.79% QoQ and 10.70% YoY. Even on a standalone basis, cost of materials consumed rose to 76.4% of revenue this quarter versus roughly 69% in both Q1 FY27 and Q2 FY26 — raw material cost pressure (styrene monomer pricing, flagged by management last quarter as elevated at $1,100–$1,400 versus a pre-war ~$1,000) is outpacing finished-product price pass-through, which management had expected to normalize. Depreciation rose modestly (₹30.36 Cr consolidated vs ₹26.16 Cr YoY) consistent with ongoing ABS capacity expansion capex.

₹
1,737.531,945.412,153.32,361.192,569.071,81807-2708-1809-0910-0510-28Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹1,818, down 12% over the past month of trading.

₹ Cr
051.63103.26154.951.92Q1 FY26rev ₹944 Cr44.72Q2 FY26rev ₹799 Cr16.34Q3 FY26rev ₹869 Cr73.48Q4 FY26rev ₹826 Cr138.3Q1 FY27rev ₹1,011 Cr23.17Q2 FY27rev ₹994 Cr
Quarterly consolidated PAT, ₹ Crore
Beyond the headline

What the summary numbers don't show

No exceptional items in the current or comparative periods — results approved by the Board on Oct 28, 2026

What management guided (1 FY-2027 call)
ABS capacity expansion on track for FY27 completion (Q3–Q4, no precision given). Raw material pricing volatility (styrene monomer $1100–$1400 currently vs $1000 pre-war) to persist; finished product pricing expected to normalize with input costs. Volume recovery timeline uncertain; no numerical guidance provided.

— This quarter: missed

No street estimates for this quarter could be located (small-cap with limited published coverage), so vsStreet is unknown. Against management's own prior commentary — raw material volatility persisting (confirmed) but finished-product pricing normalizing with input costs (not evident this quarter, standalone COGS ratio rose) — the print reads as a miss on the pricing-normalization expectation specifically; the no-numerical-guidance caveat from the last call still applies, so this is a qualitative read, not a hard target comparison. There is no fresh management press release in the record for this result. Among the quarter's other corporate developments, the company received a ₹1.92 Cr tax demand order (25-Sep-26) — immaterial relative to the P&L and not booked as an exceptional item; the ₹23 interim dividend, AGM notice, and BRSR/annual report filings in August are routine and unrelated to this quarter's operating numbers.

  • W1

    Whether the Thailand subsidiary's ₹29.62 Cr quarterly loss is one-off or recurring — next quarter's standalone-vs-consolidated gap will show the trend

  • W2

    Raw material cost trajectory (styrene monomer pricing) and whether finished-product pricing catches up, as management previously guided it would

  • W3

    ABS capacity expansion progress against management's Q3–Q4 FY27 completion timeline, visible via CWIP (₹181–185 Cr) converting to operating assets

Informational and educational content only. Not investment advice.